Compile Data Set for Download or QSAR
Report error Found 188 Enz. Inhib. hit(s) with all data for entry = 11875
TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656113(US20240072809, Compound A90)
Affinity DataKd: <5.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656115(US20240072809, Compound A92)
Affinity DataKd: >1.00E+6nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656116(US20240072809, Compound A95)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656120(US20240072809, Compound A99)
Affinity DataKd: >1.00E+6nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656124(US20240072809, Compound A100)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656127(US20240072809, Compound A103)
Affinity DataKd: <5.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656131(US20240072809, Compound A105)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656132(US20240072809, Compound A106)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656136(US20240072809, Compound A107)
Affinity DataKd: >1.00E+6nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656141(US20240072809, Compound A108)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656143(US20240072809, Compound A109)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656144(US20240072809, Compound A110)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656145(US20240072809, Compound A112)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656146(US20240072809, Compound A113)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656147(US20240072809, Compound A114)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656148(US20240072809, Compound A116)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656149(US20240072809, Compound A117)
Affinity DataKd: <5.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656150(US20240072809, Compound A118)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656151(US20240072809, Compound A119)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656152(US20240072809, Compound A120)
Affinity DataKd: <5.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656153(US20240072809, Compound A121)
Affinity DataKd: <5.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656154(US20240072809, Compound A127)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656155(US20240072809, Compound A128)
Affinity DataKd: >1.00E+6nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656156(US20240072809, Compound A160)
Affinity DataKd: >1.00E+6nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656157(US20240072809, Compound A162)
Affinity DataKd: >1.00E+6nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656158(US20240072809, Compound A164)
Affinity DataKd: <1.00E+6nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656159(US20240072809, Compound A181)
Affinity DataKd: <5.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656160(US20240072809, Compound A182)
Affinity DataKd: >1.00E+6nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656161(US20240072809, Compound A183)
Affinity DataKd: <5.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656162(US20240072809, Compound A184)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656163(US20240072809, Compound A187)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656164(US20240072809, Compound A191)
Affinity DataKd: >1.00E+6nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656165(US20240072809, Compound A192)
Affinity DataKd: >1.00E+6nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656166(US20240072809, Compound A193)
Affinity DataKd: <5.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656167(US20240072809, Compound A196)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656168(US20240072809, Compound A209)
Affinity DataKd: >1.00E+6nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656169(US20240072809, Compound A217)
Affinity DataKd: >1.00E+6nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656170(US20240072809, Compound A283)
Affinity DataKd: <5.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656171(US20240072809, Compound A284)
Affinity DataKd: <5.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656172(US20240072809, Compound A285)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656173(US20240072809, Compound A286)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656174(US20240072809, Compound 20)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656175(US20240072809, Compound 21)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656176(US20240072809, Compound 22)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656177(US20240072809, Compound 23)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656178(US20240072809, Compound 24)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656179(US20240072809, Compound 25)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656180(US20240072809, Compound 26)
Affinity DataKd: <1.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656181(US20240072809, Compound A127-2c)
Affinity DataKd: >2.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetAsialoglycoprotein receptor 1(Human)
Avilar Therapeutics

US Patent
LigandPNGBDBM656182(US20240072809, Compound A131)
Affinity DataKd: <5.00E+5nMAssay Description:The dissociation constants (KD) of compounds described herein to the ASGP receptor are measured in SPR experiments using a Biacore 8K instrument (GE ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 188 total ) | Next | Last >>
Jump to: